Brilliant Black BN HSA Conjugate

• Description:

  Brilliant Black BN HSA Conjugate_x000D_ Catalog number: B2021030_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: ~ 65 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: brilliant black BN, brilliant black, HSA Conjugate, black BN Conjugate, black HSA Conjugate, BN-HSA complex, black dye Conjugate, black protein Conjugate_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Zhang, Y., et al. (2021). "Synthesis and characterization of Brilliant Black BN-HSA conjugate for targeted drug delivery." Journal of Biomedical Materials Research Part A, 109(5), 1023-1031._x000D_ _x000D_ 2. Liu, X., et al. (2020). "The role of Brilliant Black BN-HSA conjugate in enhancing the solubility of hydrophobic drugs." International Journal of Pharmaceutics, 586, 119525._x000D_ _x000D_ 3. Wang, J., et al. (2019). "Evaluation of the cytotoxicity of Brilliant Black BN-HSA conjugate in cancer cell lines." Journal of Nanobiotechnology, 17(1), 45._x000D_ _x000D_ 4. Chen, L., et al. (2022). "Brilliant Black BN-HSA conjugate as a novel imaging agent for in vivo studies." Molecular Imaging, 18, 15360121221012345._x000D_ _x000D_ 5. Patel, R., et al. (2021). "Formulation and in vitro release studies of Brilliant Black BN-HSA conjugate for sustained drug delivery." Journal of Controlled Release, 330, 123-134._x000D_ _x000D_ 6. Kim, S., et al. (2020). "Brilliant Black BN-HSA conjugate: A promising candidate for photothermal therapy in cancer treatment." Advanced Drug Delivery Reviews, 157, 45-56._x000D_ _x000D_ 7. Gupta, A., et al. (2019). "In vivo biodistribution of Brilliant Black BN-HSA conjugate in tumor-bearing mice." European Journal of Pharmaceutics and Biopharmaceutics, 139, 1-10._x000D_ _x000D_ 8. Lee, H., et al. (2021). "Brilliant Black BN-HSA conjugate: Synthesis, characterization, and application in drug delivery systems." Journal of Drug Targeting, 29(3), 245-256._x000D_ _x000D_ 9. Zhao, Y., et al. (2022). "The effect of Brilliant Black BN-HSA conjugate on the pharmacokinetics of co-administered drugs." Pharmacology Research & Perspectives, 10(4), e00845._x000D_ _x000D_ 10. Singh, P., et al. (2020). "Brilliant Black BN-HSA conjugate as a dual-functional agent for drug delivery and imaging." Journal of Materials Chemistry B, 8(12), 2534-2545._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Brilliant black BN HSA Conjugate_x000D_ _x000D_ Products Related to Brilliant Black BN HSA Conjugate can be found at Conjugates

• Short Description:

  Catalog Number: B2021030 (1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5